Maksim Labkouski Ono Pharmaceutical has successfully completed its $2.4B tender offer for Deciphera Pharmaceuticals ( NASDAQ: DCPH ). As a result of the transaction , Deciphera is now a wholly owned subsidiary of Ono, with shares no longer trading on Nasdaq.
Ono offered $25.60 per share for Deciphera. The deal was first announced in late April.
More on Deciphera Pharmaceuticals Diving Into Deciphera Pharmaceuticals Deciphera Pharmaceuticals ticks higher as HSR waiting period for ONO sale expires ONO to acquire Deciphera Pharmaceuticals in $2.4B deal Seeking Alpha’s Quant Rating on Deciphera Pharmaceuticals Historical earnings data for Deciphera Pharmaceuticals.
